GRM2 and schizophrenia: It is still unclear whether this enhancement (either NMDA receptor current or other currents) is associated with the antipsychotic potency of mGluR2/3 agonists but undoubtedly, they can provide normalization of glutamate levels and NMDA receptor function in schizophrenia.